Edition:
United States

Consumer Goods & Retail Headlines

Cholesterol drug maker pays $4.1 mln to settle fraud charges-SEC

Aegerion Pharmaceuticals, a subsidiary of Novelion Therapeutics, will pay $4.1 million to settle charges it misled investors about how many patients purchased Juxtapid, a drug used to treat a genetic condition that leads to high cholesterol, the top U.S. securities regulator said on Friday.

PRESS DIGEST- Canada - Sept 22

The following are the top stories from selected Canadian newspapers. Reuters has not verified these stories and does not vouch for their accuracy.

Photo

U.S. challenged by rising North Korea tensions, Russia urges calm

UNITED NATIONS Russia urged "hot heads" to calm down on Friday as the United States admitted it felt "challenged" by North Korea's warning that it could test a hydrogen bomb over the Pacific and President Donald Trump and Kim Jong Un traded more insults. | Video